Answers are grounded in this paper and cite their sources.
Genetic modification for cancer treatment has involved the introduction of chemotherapy protection and sensitization genes into normal and tumor cells, respectively, for the purpose of improving the outcome of conventional approaches to the treatment of solid tumor neoplasms. This paper will review the use of multidrug resistance-1 retroviral vectors and cytosine deaminase adenoviral prodrug activation vectors for this purpose.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: